|
|
|
½ÃÀ庸°í¼
Â÷±â ¹é½ÅÀº ¹«¾ùÀΰ¡? : 2010¡2020³âÀÇ ÆÄÀÌÇÁ¶óÀο¡¼ HIV, ¸»¶ó¸®¾Æ, ±¤°ßº´, MRSA, ±âŸ 30°¡Áö°¡ ³Ñ´Â ¹é½Å Ç¥Àû
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
|
Kalorama Information ¿¡¼ 2010³â 02¿ù ¿¡ ¹ßÇàÇÑ ¡¸Â÷±â ¹é½ÅÀº ¹«¾ùÀΰ¡? : 2010¡2020³âÀÇ ÆÄÀÌÇÁ¶óÀο¡¼ HIV, ¸»¶ó¸®¾Æ, ±¤°ßº´, MRSA, ±âŸ 30°¡Áö°¡ ³Ñ´Â ¹é½Å Ç¥Àû¡¹ º¸°í¼´Â 220 pages·Î ±¸¼ºµÇ¾î, US $4,200 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.
2020³â±îÁöÀÇ ´Ù¾çÇÑ ¹é½Å °³¹ß µ¿Çâ ¹× ¼öÀÍ ¿¹ÃøÀ» Á¤¸®ÇÏ°í ½ÃÀå ±¸ºÐº° ¼¼°èÀÇ ¼öÀÍ, Âü°¡ ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù. Á¦2Àå ¹é½ÅÀÇ ¼·Ð - ¾à·Â : ¹é½ÅÀÇ ¹ßÀü
- ¸é¿ª ¹ÝÀÀ
- ÀÛ¿ë ±â¼
- ¹é½ÅÀÇ Á¾·ù
- ¹é½Å ½ÂÀÎ ÇÁ·Î¼¼½º
- ¹é½Å ½ÃÀåÀ» ÃËÁøÇÏ´Â µ¿Çâ
Á¦3Àå ½ÅÈï ¹é½Å - ¼·Ð
- Áúȯº° ½ÅÈï ¹é½Å
- Áßµ¶
- ¾Ë·¹¸£±â
- ¾ËÃ÷ÇÏÀ̸Ӻ´
- źÀú±Õ
- õ½Ä
- Ŭ¶ó¹Ìµð¾Æ µî
Á¦4Àå ½ÅÈï ¹é½Å ½ÃÀå ¿¹Ãø - ¼¼°èÀÇ ½ÅÈï ¹é½Å ½ÃÀå
- ½ÅÈï ¹é½Å ½ÃÀå ±¸ºÐº° ¿¹Ãø
Á¦5Àå °úÁ¦ ¹× µ¿Çâ - »õ·Î¿î ¹é½Å ±â¼ú
- DNA ¹é½Å
- Çõ½ÅÀû µô¸®¹ö¸® ½Ã½ºÅÛ
- ÀÚ±Ý ºÎÁ·
Á¦6Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ - Acambis plc
- ACE BioSciences
- AFFiRiS
- ALK-Abello A/S
- Allergy Therapeutics
- Bavarian Nordic A/S
- Baxter Healthcare
- Celldex Therapeutics
- Crucell
- Cytos Biotechnology
- GlaxoSmithKline
- Hawaii Biotech
- Intercell
- Medimmune
- Merck & Co. Inc
- Mymetics
- Nabi Biopharmaceuticals
- Novartis
- Opexa Therapeutics
- Paladin Labs
- Sanofi Pasteur
PMH
|

|